GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $19,000 | -24.0% | 445 | -33.1% | 0.01% | 0.0% |
| Q3 2021 | $25,000 | -3.8% | 665 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $26,000 | +8.3% | 665 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $24,000 | 0.0% | 665 | 0.0% | 0.01% | -10.0% |
| Q4 2020 | $24,000 | +9.1% | 665 | +12.5% | 0.01% | -9.1% |
| Q3 2020 | $22,000 | -8.3% | 591 | 0.0% | 0.01% | -15.4% |
| Q2 2020 | $24,000 | +4.3% | 591 | 0.0% | 0.01% | -55.2% |
| Q1 2020 | $23,000 | -28.1% | 591 | -21.8% | 0.03% | +38.1% |
| Q3 2019 | $32,000 | +3.2% | 756 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $31,000 | 0.0% | 756 | 0.0% | 0.02% | -4.5% |
| Q1 2019 | $31,000 | +6.9% | 756 | 0.0% | 0.02% | -4.3% |
| Q4 2018 | $29,000 | -6.5% | 756 | 0.0% | 0.02% | +9.5% |
| Q3 2018 | $31,000 | +19.2% | 756 | +17.0% | 0.02% | +10.5% |
| Q2 2018 | $26,000 | -60.0% | 646 | -61.2% | 0.02% | -60.4% |
| Q1 2018 | $65,000 | – | 1,665 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |